iwNHL 2019 Session V: Novel Lymphoma Targets/Agents

Oral PI3K-δ and PI3K-γ inhibitors in lymphoma

Sven de Vos

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter